CVS Group (LON:CVSG) Earns “Outperform” Rating from Royal Bank Of Canada

CVS Group (LON:CVSG)‘s stock had its “outperform” rating reiterated by analysts at Royal Bank Of Canada in a note issued to investors on Thursday, Marketbeat.com reports. They currently have a GBX 1,900 price objective on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 48.44% from the company’s current price.

Other research analysts have also recently issued research reports about the company. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Tuesday, November 18th. Peel Hunt restated a “buy” rating and set a GBX 1,600 price objective on shares of CVS Group in a research note on Tuesday, November 18th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of GBX 1,724.

CVS Group Trading Up 0.2%

LON:CVSG opened at GBX 1,280 on Thursday. The company has a debt-to-equity ratio of 121.52, a current ratio of 1.07 and a quick ratio of 0.90. CVS Group has a one year low of GBX 885 and a one year high of GBX 1,648. The company has a market cap of £898.00 million, a PE ratio of 17.39, a PEG ratio of 1.77 and a beta of 1.31. The firm has a 50-day moving average of GBX 1,339.20 and a 200-day moving average of GBX 1,283.27.

CVS Group (LON:CVSG) last announced its quarterly earnings results on Thursday, February 26th. The company reported GBX 40.20 earnings per share for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. As a group, equities research analysts expect that CVS Group will post 93.9393939 EPS for the current fiscal year.

Insider Transactions at CVS Group

In other news, insider Richard Gray acquired 2,000 shares of the firm’s stock in a transaction on Monday, January 5th. The stock was purchased at an average price of £1,276.96 per share, for a total transaction of £2,553,920. Insiders own 1.42% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.